CT灌注预测缺血性卒中血管再通治疗反应
本研究为多中心队列研究,纳入201例急性卒中患者,评估CT灌注用于筛选发病18小时内接受血管内治疗患者的效用。在目标错配患者中,再灌注与良好临床反应相关(83% vs 44%,校正OR=6.6)。
要点
- CT灌注目标错配可筛选发病18小时内适合血管内治疗的患者。
- 目标错配患者再灌注后良好临床反应率83% vs 44%。
- 6小时内与超过6小时治疗的患者获益关联无差异。
核心结论
- 在CT灌注目标错配患者中,发病18小时内血管内再灌注与良好预后强相关,支持开展随机试验。
研究设计与样本
- 多中心队列研究,连续纳入计划在基线CT灌注后90分钟内接受血管内治疗的急性卒中患者。
- 201例入组,190例有合格基线CT灌注且接受血管造影者纳入分析(平均年龄66岁,中位NIHSS=16,中位发病至血管内治疗时间5.2小时)。
主要发现
- 再灌注率为89%。
- 目标错配患者(n=131)中,再灌注与良好临床反应(NIHSS改善≥8分)相关:83% vs 44%,p=0.002,校正OR=6.6,95%CI=2.1-20.9。
- 该关联在6小时内治疗(OR=6.4,95%CI=1.5-27.8)与超过6小时治疗(OR=13.7,95%CI=1.4-140)的患者间无差异。
关键数值与推荐
- 目标错配定义为基线CT灌注显示小缺血核心和大缺血半暗带。
- 再灌注定义为基线CT灌注与36小时随访MRI之间关键低灌注减少>50%。
- 良好临床反应定义为NIHSS改善≥8分。
临床怎么用
- 对发病18小时内的急性缺血性卒中患者,可用CT灌注目标错配筛选血管内治疗候选者。
- 再灌注与良好临床反应的强关联支持在此类患者中开展随机对照试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the utility of computed tomographic (CT) perfusion for selection of patients for endovascular therapy up to 18 hours after symptom onset. METHODS: We conducted a multicenter cohort study of consecutive acute stroke patients scheduled to undergo endovascular therapy within 90 minutes after a baseline CT perfusion. Patients were classified as "target mismatch" if they had a small ischemic core and a large penumbra on their baseline CT perfusion. Reperfusion was defined as >50% reduction in critical hypoperfusion between the baseline CT perfusion and the 36-hour follow-up magnetic resonance imaging. RESULTS: Of the 201 patients enrolled, 190 patients with an adequate baseline CT perfusion study who underwent angiography were included (mean age = 66 years, median NIH Stroke Scale [NIHSS] = 16, median time from symptom onset to endovascular therapy = 5.2 hours). Rate of reperfusion was 89%. In patients with target mismatch (n = 131), reperfusion was associated with higher odds of favorable clinical response, defined as an improvement of ≥8 points on the NIHSS (83% vs 44%; p = 0.002, adjusted odds ratio [OR] = 6.6, 95% confidence interval [CI] = 2.1-20.9). This association did not differ between patients treated within 6 hours (OR = 6.4, 95% CI = 1.5-27.8) and those treated > 6 hours after symptom onset (OR = 13.7, 95% CI = 1.4-140). INTERPRETATION: The robust association between endovascular reperfusion and good outcome among patients with the CT perfusion target mismatch profile treated up to 18 hours after symptom onset supports a randomized trial of endovascular therapy in this patient population. Ann Neurol 2017;81:849-856.
引用
- Lansberg MG, Christensen S, Kemp S, et al. Computed tomographic perfusion to Predict Response to Recanalization in ischemic stroke. Ann Neurol. 2017. PMID: 28486789. doi:10.1002/ana.24953
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。